Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$170.78 - $208.42 $46.2 Million - $56.4 Million
-270,770 Reduced 29.89%
634,990 $117 Million
Q4 2023

Feb 09, 2024

SELL
$114.17 - $185.35 $4.7 Million - $7.62 Million
-41,133 Reduced 4.34%
905,760 $163 Million
Q3 2023

Nov 09, 2023

BUY
$138.78 - $176.51 $142,110 - $180,746
1,024 Added 0.11%
946,893 $151 Million
Q2 2023

Aug 10, 2023

BUY
$138.42 - $180.31 $4.78 Million - $6.22 Million
34,501 Added 3.79%
945,869 $134 Million
Q1 2023

May 12, 2023

BUY
$154.26 - $198.1 $36.7 Million - $47.1 Million
237,796 Added 35.3%
911,368 $153 Million
Q4 2022

Feb 09, 2023

BUY
$162.42 - $220.56 $20.5 Million - $27.8 Million
126,188 Added 23.05%
673,572 $114 Million
Q3 2022

Nov 09, 2022

SELL
$160.42 - $256.21 $29.8 Million - $47.6 Million
-185,702 Reduced 25.33%
547,384 $102 Million
Q2 2022

Aug 10, 2022

BUY
$140.68 - $188.02 $103 Million - $138 Million
733,086 New
733,086 $119 Million
Q4 2018

Feb 13, 2019

SELL
$48.26 - $68.88 $65.8 Million - $93.9 Million
-1,363,109 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$46.8 - $58.97 $20.7 Million - $26.1 Million
-443,195 Reduced 24.54%
1,363,109 $75.6 Million
Q2 2018

Aug 14, 2018

SELL
$35.26 - $47.04 $14,068 - $18,768
-399 Reduced 0.02%
1,806,304 $85 Million
Q1 2018

May 14, 2018

BUY
$30.92 - $37.27 $127,823 - $154,074
4,134 Added 0.23%
1,806,703 $65.4 Million
Q4 2017

Feb 14, 2018

BUY
$32.53 - $38.92 $24.2 Million - $28.9 Million
742,634 Added 70.06%
1,802,569 $65.4 Million
Q3 2017

Nov 13, 2017

BUY
$36.98 - $46.06 $39.2 Million - $48.8 Million
1,059,935
1,059,935 $40.6 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.